標(biāo)題: Titlebook: Cancer Proteomics; From Bench to Bedsid Sayed S. Daoud Book 2008 Humana Press 2008 Bioinformatics.Cancer Research.Carcinom.Oncology.Proteom [打印本頁(yè)] 作者: bradycardia 時(shí)間: 2025-3-21 16:40
書(shū)目名稱Cancer Proteomics影響因子(影響力)
作者: 案發(fā)地點(diǎn) 時(shí)間: 2025-3-21 21:39 作者: 用手捏 時(shí)間: 2025-3-22 02:58
Cancer Proteomics978-1-59745-169-7Series ISSN 2196-9906 Series E-ISSN 2196-9914 作者: essential-fats 時(shí)間: 2025-3-22 07:38
PSED II and the Kauffman Firm SurveyThis chapter describes the key elements in tumor biomarker development toward clinical use. In particular, it focuses on the analytical aspects of assay development and how to implement new tumor biomarkers in the clinical setting.作者: Mercurial 時(shí)間: 2025-3-22 09:06 作者: foreign 時(shí)間: 2025-3-22 16:57
https://doi.org/10.1007/978-1-59745-169-7Bioinformatics; Cancer Research; Carcinom; Oncology; Proteomics; Translation; classification; diagnostics; p作者: foreign 時(shí)間: 2025-3-22 20:00
New Feminist Perspectives on Embodiment merited the Nobel Prize were especially revolutionary examples, but mass analyzer design, ion chemistry, ion detection, and data analysis have all seen significant performance advances. In the area of proteomics, the key moment for any of these innovations and advances comes when they are transferr作者: 不妥協(xié) 時(shí)間: 2025-3-22 23:02 作者: 使熄滅 時(shí)間: 2025-3-23 05:14
https://doi.org/10.1007/978-1-349-22450-0ions, prediction of clinical outcome and monitoring response to cancer treatments. The exciting move toward kinase-targeted therapy has brought new technical challenges in profiling protein kinase genes and proteins as surrogate clinical biomarkers, particularly in light of clinical data correlating作者: 思想靈活 時(shí)間: 2025-3-23 07:58
New Findings in Long-Wave Research individual. Numerous proteomic technologies are available, and selected ones relevant to development of personalized therapy are described. Cancer biomarkers discovered by proteomics can be used for diagnosis as well as drug targets, thus facilitating the integration of diagnostics and therapeutics作者: 確定無(wú)疑 時(shí)間: 2025-3-23 10:38 作者: 防銹 時(shí)間: 2025-3-23 13:56 作者: indices 時(shí)間: 2025-3-23 18:54 作者: prolate 時(shí)間: 2025-3-24 00:09 作者: 菊花 時(shí)間: 2025-3-24 04:14
Richard T. Curtin,Paul D. Reynoldsl components including genes. Improved gene prediction algorithms together with existing transcript and protein information have enabled the identification of most exons in a genome. Availability of the ‘parts list’ has enabled systematic interrogation of gene function on genome, transcriptome and p作者: 故意釣到白楊 時(shí)間: 2025-3-24 09:25 作者: Diverticulitis 時(shí)間: 2025-3-24 10:41 作者: 不能強(qiáng)迫我 時(shí)間: 2025-3-24 14:56
Insight on Renal Cell Carcinoma Proteomeg the great work done by several groups and the enormous amount of information present in literature, knowledge about its pathogenesis is still incomplete, and several markers of RCC are proposed but not yet validated.作者: 征稅 時(shí)間: 2025-3-24 20:49 作者: heterogeneous 時(shí)間: 2025-3-25 01:42
New Findings in Long-Wave Researchomarkers discovered by proteomics can be used for diagnosis as well as drug targets, thus facilitating the integration of diagnostics and therapeutics. Proteomics fulfills many of the requirements for personalized therapy of cancer.作者: 不可磨滅 時(shí)間: 2025-3-25 05:23
Paul D. Reynolds,Richard T. Curtinlinical study designs with representative patient populations and effective controls, and addressing issues of biological validations and potential bias associated with predictive biomarker validation.作者: 中和 時(shí)間: 2025-3-25 09:37
Oncoproteomics for Personalized Management of Canceromarkers discovered by proteomics can be used for diagnosis as well as drug targets, thus facilitating the integration of diagnostics and therapeutics. Proteomics fulfills many of the requirements for personalized therapy of cancer.作者: frivolous 時(shí)間: 2025-3-25 13:05 作者: metropolitan 時(shí)間: 2025-3-25 16:11 作者: 笨重 時(shí)間: 2025-3-25 22:54
D. Lutz,O. Krieger,H. Kasparu,E. Fiedlerg the great work done by several groups and the enormous amount of information present in literature, knowledge about its pathogenesis is still incomplete, and several markers of RCC are proposed but not yet validated.作者: evasive 時(shí)間: 2025-3-26 03:14 作者: 現(xiàn)代 時(shí)間: 2025-3-26 04:25 作者: Diatribe 時(shí)間: 2025-3-26 10:53
Current and Emerging Mass Spectrometry Instrumentation and Methods for Proteomic Analyseslaser desorption/ionization mature to the point that MS is now ubiqitous part of life science research and experiments that were once cutting edge have become routine. Similarly, the new methods described in this chapter are also beginning to pass this transfer test to produce unique results in a variety of biological systems.作者: 譏諷 時(shí)間: 2025-3-26 13:12
2196-9906 ch more feasible to do effective clinical trials of these small molecules alone and in combinations to overcome drug resistance and improve patient care. The third part of the book moves from signaling to actua978-1-61737-807-2978-1-59745-169-7Series ISSN 2196-9906 Series E-ISSN 2196-9914 作者: 消極詞匯 時(shí)間: 2025-3-26 17:40
Integration of Genomics and Proteomics in Dissecting p53 Signaling others have used gene expression profiling with microarrays to isolate p53 target genes in an attempt to understand the molecular signaling of p53 and to determine the molecular consequences that follow from treatment of cancer cells with chemotherapeutic agents. Although these attempts have been s作者: bleach 時(shí)間: 2025-3-26 23:20
Application of Serum and Tissue Proteomics to Understand and Detect Solid Tumorsthe tumor as well as from the tumor microenvironment, as demonstrated in our two recent clinical trials employing these analyses to evaluate effects of targeted agents. Proteomic techniques strengthen the link between bench and bedside by testing existing hypotheses about a disease state or treatmen作者: Conspiracy 時(shí)間: 2025-3-27 04:26
Proteomics in Lung Cancerhiogenic cancer were detected in human breath. (4) Proteins were profiled in malignant pleural effusion. Functional studies have highlighted modifications of several kinases and cell cycle proteins in lung cancer, some of them might have therapeutic potential. These studies have also suggested addit作者: 甜食 時(shí)間: 2025-3-27 08:09
Proteomic Strategies of Therapeutic Individualization and Target Discovery in Acute Myeloid Leukemiatential in directly investigating pathways that are targeted by small molecules or therapeutic antibodies. The major methodological challenges include detection sensitivity in a limited clinical material. In this chapter, we will discuss pharmacoproteomic studies of drugs regulating epigenetics, gen作者: cartilage 時(shí)間: 2025-3-27 12:07 作者: modifier 時(shí)間: 2025-3-27 14:15 作者: 施舍 時(shí)間: 2025-3-27 20:27 作者: Comprise 時(shí)間: 2025-3-28 01:30 作者: Intuitive 時(shí)間: 2025-3-28 06:09
D. Lutz,O. Krieger,H. Kasparu,E. Fiedlerhiogenic cancer were detected in human breath. (4) Proteins were profiled in malignant pleural effusion. Functional studies have highlighted modifications of several kinases and cell cycle proteins in lung cancer, some of them might have therapeutic potential. These studies have also suggested addit作者: Excise 時(shí)間: 2025-3-28 08:31 作者: 向外 時(shí)間: 2025-3-28 13:51 作者: arbiter 時(shí)間: 2025-3-28 18:11 作者: 擴(kuò)大 時(shí)間: 2025-3-28 19:27 作者: nuclear-tests 時(shí)間: 2025-3-28 23:07
Proteomic Profiling of Tyrosine Kinases as Pharmacological Endpoints for Targeted Cancer Therapyions, prediction of clinical outcome and monitoring response to cancer treatments. The exciting move toward kinase-targeted therapy has brought new technical challenges in profiling protein kinase genes and proteins as surrogate clinical biomarkers, particularly in light of clinical data correlating作者: osteoclasts 時(shí)間: 2025-3-29 05:31
Oncoproteomics for Personalized Management of Cancer individual. Numerous proteomic technologies are available, and selected ones relevant to development of personalized therapy are described. Cancer biomarkers discovered by proteomics can be used for diagnosis as well as drug targets, thus facilitating the integration of diagnostics and therapeutics作者: NAVEN 時(shí)間: 2025-3-29 09:04
Application of Serum and Tissue Proteomics to Understand and Detect Solid Tumorse detailed analysis of a diverse set of proteins and their isoforms at the molecular level. These new, high-throughput, and comprehensive proteomic studies can be useful in advancing our understanding of disease processes and have wide potential for integration within clinical trials. Clinical trial作者: Euphonious 時(shí)間: 2025-3-29 15:07 作者: hauteur 時(shí)間: 2025-3-29 18:42
